Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
British Journal of Clinical Pharmacology
|
March 12, 2011
Population pharmacokinetic analysis of sorafenib in patients with solid tumours
Lokesh Jain, Sukyung Woo, Erin R Gardner, et al.
Plos One
|
January 21, 2011
Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers
Ryszard M Pluta, Edward H Oldfield, Kamran D Bakhtian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 29, 2012
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors
Arun Rajan, Corey A Carter, Ronan J Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma
Sukyung Woo, Erin R Gardner, Xiaohong Chen, et al.
The Journal of Urology
|
April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer
William D Figg, Sukyung Woo, Wenhui Zhu, et al.
Molecular Therapy. Nucleic Acids
|
December 14, 2016
E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases
Yoshihiro Morita, Mohamed Kamal, Shin-Ae Kang, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
Ultra-Long-Term Delivery of Hydrophilic Drugs Using Injectable <i>In Situ</i> Cross-Linked Depots
Sohyung Lee, Spencer Zhao, Weihua Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2012
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia
Cody J Peer, Tristan M Sissung, Aerang Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer
Yang-Min Ning, James L Gulley, Philip M Arlen, et al.
RSC Medicinal Chemistry
|
June 11, 2025
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy
Ujjwol Khatri, Neetu Dayal, Kofi B Owusu, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
British Journal of Clinical Pharmacology
|
March 12, 2011
Population pharmacokinetic analysis of sorafenib in patients with solid tumours
Lokesh Jain, Sukyung Woo, Erin R Gardner, et al.
Plos One
|
January 21, 2011
Safety and feasibility of long-term intravenous sodium nitrite infusion in healthy volunteers
Ryszard M Pluta, Edward H Oldfield, Kamran D Bakhtian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 29, 2012
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors
Arun Rajan, Corey A Carter, Ronan J Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma
Sukyung Woo, Erin R Gardner, Xiaohong Chen, et al.
The Journal of Urology
|
April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer
William D Figg, Sukyung Woo, Wenhui Zhu, et al.
Molecular Therapy. Nucleic Acids
|
December 14, 2016
E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases
Yoshihiro Morita, Mohamed Kamal, Shin-Ae Kang, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2024
Ultra-Long-Term Delivery of Hydrophilic Drugs Using Injectable <i>In Situ</i> Cross-Linked Depots
Sohyung Lee, Spencer Zhao, Weihua Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2012
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemia
Cody J Peer, Tristan M Sissung, Aerang Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer
Yang-Min Ning, James L Gulley, Philip M Arlen, et al.
RSC Medicinal Chemistry
|
June 11, 2025
Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy
Ujjwol Khatri, Neetu Dayal, Kofi B Owusu, et al.
Page
of 7